The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neutrophil to lymphocyte ratio, PD-L1 expression, and survival in patients with advanced non-small cell lung cancer receiving first-line immune checkpoint inhibitor therapy.
 
Mingjia Li
No Relationships to Disclose
 
Songzhu Zhao
No Relationships to Disclose
 
Daniel Spakowicz
No Relationships to Disclose
 
Jarred Thomas Burkart
No Relationships to Disclose
 
Sandip H. Patel
No Relationships to Disclose
 
Marium Husain
No Relationships to Disclose
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
Erin Marie Bertino
Consulting or Advisory Role - Boehringer Ingelheim; Takeda
 
Peter G. Shields
No Relationships to Disclose
 
Lai Wei
Consulting or Advisory Role - Bexion
 
Carolyn J Presley
Consulting or Advisory Role - PotentiaMetrics
Research Funding - Celgene (Inst)
 
Gregory Alan Otterson
Consulting or Advisory Role - Novartis; Novocure; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Palobiofarma (Inst)
Travel, Accommodations, Expenses - AstraZeneca